Umoja Biopharma has secured $100 million in series C funds as the cancer-focused biotech looks to bring more of its cell therapies into the clinic. Umoja’s only clinical-stage candidate is UB ...
Almost 50 years later, at 66 years old, Umoja still observes the holiday and enjoys it with her family. “Kwanzaa is a wonderful time, because we talk about the issues Black people are facing and ...
On the first day of the Kwanzaa holiday, people in Greater Cincinnati are celebrating the principle of unity, called Umoja.The Cincinnati Citywide Kwanzaa Committee is celebrating the occasion ...
SEATTLE, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells ...
GeekWire’s startup coverage documents the Pacific Northwest entrepreneurial scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and venture capital ...